O Keefe Stevens Advisory Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 19.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 400 shares of the healthcare conglomerate’s stock after selling 99 shares during the period. O Keefe Stevens Advisory Inc.’s holdings in UnitedHealth Group were worth $212,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors also recently added to or reduced their stakes in the company. TimeScale Financial Inc. raised its position in UnitedHealth Group by 276.9% during the third quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock worth $25,000 after acquiring an additional 36 shares during the period. Pflug Koory LLC raised its position in UnitedHealth Group by 160.0% during the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 32 shares during the period. Belmont Capital LLC raised its position in UnitedHealth Group by 294.1% during the third quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock worth $34,000 after acquiring an additional 50 shares during the period. O Dell Group LLC raised its position in UnitedHealth Group by 76.9% during the third quarter. O Dell Group LLC now owns 69 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 30 shares during the period. Finally, Legend Financial Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter worth $37,000. 86.31% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
UNH has been the subject of a number of research reports. UBS Group dropped their target price on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating for the company in a report on Wednesday, January 18th. Morgan Stanley reaffirmed an “overweight” rating and set a $587.00 target price on shares of UnitedHealth Group in a report on Wednesday, November 23rd. StockNews.com raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 11th. Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a report on Tuesday, February 28th. Finally, Loop Capital upped their price objective on shares of UnitedHealth Group from $575.00 to $590.00 in a report on Tuesday, January 17th. Three analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $599.68.
UnitedHealth Group Stock Down 0.5 %
UnitedHealth Group (NYSE:UNH – Get Rating) last issued its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.17 by $0.17. The business had revenue of $82.79 billion for the quarter, compared to analysts’ expectations of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The business’s quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.48 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 24.91 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 21st. Investors of record on Monday, March 13th will be issued a $1.65 dividend. The ex-dividend date is Friday, March 10th. This represents a $6.60 annualized dividend and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.15%.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.